Table 2.
Examples of proteins that were upregulated and correlate with enhanced late and total apoptosis levels after RT2 treatment.
| Accession | Protein Name | Gene Name |
Anova (p) | q Value | Treatment Effect (Fold Change) | ||
|---|---|---|---|---|---|---|---|
| Caco-2 Treated with 15 µM RT2 Compared to Untreated Control | Caco-2 Treated with 30 µM RT2 Compared to Untreated Control | Caco-2 Treated with 60 µM RT2 Compared to Untreated Control | |||||
| Q9Y3M8.2 | StAR-related lipid transfer protein 13 | STARD13 | 0.01026 | 0.00083 | +1.03 | +1.51 | +1.38 |
| Q9ULD0.3 | 2-oxoglutarate dehydrogenase-like, mitochondrial | OGDHL | 0.00001 | 0.00000 | −1.02 | +1.25 | +2.20 |
| Q04726.2 | Transducin-like enhancer protein 3 | TLE3 | 0.00093 | 0.00014 | −1.00 | +1.14 | +1.27 |
| O75140.2 | GATOR complex protein DEPDC5 | DEPDC5 | 0.05765 | 0.00239 | +1.07 | +1.10 | +1.21 |
| P86452.1 | Zinc finger BED domain-containing protein 6 | ZBED6 | 0.00000 | 0.00000 | +1.05 | +1.41 | +3.18 |
| O43143.2 | Pre-mRNA-splicing factor ATP-dependent RNA helicase | DHX15 | 0.00000 | 0.00000 | +1.19 | +1.74 | +3.90 |
| Q9HBU1.2 | Homeobox protein BarH-like 1 | BARX1 | 0.00000 | 0.00000 | +1.05 | +1.32 | +2.15 |
| Q8TE57.3 | A disintegrin and metalloproteinase with thrombospondin motifs 16 | ADAMTS16 | 0.00173 | 0.00023 | −1.03 | +1.27 | +1.45 |
| Q13796.1 | Protein Shroom2 (Apical-like protein) (Protein APXL) | SHROOM2 | 0.00000 | 0.00000 | +1.06 | +1.06 | +1.58 |
| Q5T5X7.1 | BEN domain-containing protein 3 | BEND3 | 0.15843 | 0.00510 | +1.10 | +1.22 | +1.06 |
| O95803.1 | Bifunctional heparan sulfate N-deacetylase/ N-sulfotransferase 3 | NDST3 | 0.39396 | 0.01136 | +1.03 | +1.08 | +1.04 |
+: Proteins were upregulated; −: Proteins were downregulated.